Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000348071

Medchemexpress LLC Camizestrant | 2222844-89-3 | 99.3% | 476.51 | 50 MG
SDP

Catalog No. 5000348071
Encompass_Preferred

Camizestrant is a potent and orally active estrogen receptor (ER) antagonist. It is used for the study of ER+ HER2-advanced breast cancer. It exhibits anti-tumour efficacy in a dose-dependent manner in human parental MCF7 mice xenograft and decreases tumor growth in mice, with almost complete tumor growth inhibition at doses >10 mg/kg.

  • Potent and orally active estrogen receptor (ER) antagonist
  • Used for the study of ER+ HER2-advanced breast cancer
  • Exhibits anti-tumour efficacy in a dose-dependent manner
  • Decreases tumor growth in mice with significant inhibition at doses >10 mg/kg

Catalog No. 50-003-48071 Supplier Medchemexpress LLC Supplier No. HY13625550MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Camizestrant is a potent and orally active estrogen receptor (ER) antagonist. It is used for the study of ER+ HER2-advanced breast cancer. It exhibits anti-tumour efficacy in a dose-dependent manner in human parental MCF7 mice xenograft and decreases tumor growth in mice, with almost complete tumor growth inhibition at doses >10 mg/kg.

  • Potent and orally active estrogen receptor (ER) antagonist
  • Used for the study of ER+ HER2-advanced breast cancer
  • Exhibits anti-tumour efficacy in a dose-dependent manner
  • Decreases tumor growth in mice with significant inhibition at doses >10 mg/kg

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.